Search Go
Follow us:  linkedin twitter slideshare youtube google + pinterest
 


Medical Affairs Consortium
Our research & advisory services members:

  • Amgen
  • astellas
  • Actavis
  • BoehringerIngelheim
  • Biogen
  • Baxter
  • Celgene
  • Eisai
  • Lilly
  • Genentech
  • Incyte
  • Lundbeck
  • Merck
  • Mylan
  • Pfizer
  • Prostrakan
  • Sanofi
  • Shionogi
  • Sunovion
  • Teva
  • Upsher-Smith

What is the Medical Affairs Consortium?

The Medical Affairs Consortium is a unique opportunity for Medical Affairs leaders to discuss key challenges, share best practices, develop action-oriented solutions and uncover recent and future trends in regards to the Medical Affairs function and its interactions with other critical functions.

Service Model:

Our seasoned research team establishes Medical Affairs research information from around the healthcare sector. Armed with these critical insights, our client members then embark on a networking and performance improvement conversation utterly unique to the industry.

Formed in 2012, the Medical Affairs Consortium:

  • Has engaged nearly one hundred leading biopharma and medical device executives in benchmarking research to accelerated knowledge exchange
  • Has hosted six Medical Affairs Consortium roundtable meetings and research deliverables composed of action-oriented insights from Medical Affairs executives
  • Has developed thirteen members from top biopharmaceutical companies





2015 - 2016 key events
August
  • Launch - Medical Affairs Consortium Survey
  • Medical Affairs Executives Participate in the Survey
  • November
  • Delivery of First Wave of Research Insights & Customized Analysis
  • First Roundtable Peer Panel & Knowledge Exchange
  • Delivery of First Roundtable Key Insights
  • February
  • Delivery of Second Wave of Research Insights & Customized Analysis
  • Second Roundtable Peer Panel & Knowledge Exchange
  • Delivery of Second Roundtable Key Insights
  • June
  • Delivery of Third Wave of Research Insights & Customized Analysis
  • Third Roundtable Peer Panel & Knowledge Exchange
  • Delivery of Third Roundtable Key Insights

  • Member-driven research:
    Medical Affairs’ Role in Health Economics & Outcomes Research (ID POP-259)
    This study engaged 23 executives from 23 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices.
    Read More
    Medical Affairs’ Role in Ensuring Excellence in Product Launch (ID POP-256)
    Best Practices, LLC engaged 28 executives from 24 leading biopharmaceutical companies within mature markets. Segmentation analysis was key to examining trends and effective practices.
    Read More
    Best Practices in Developing Top-Tier Medical Affairs Capabilities, Creating Impact Measures and Improving Globalization (ID POP-255)
    This study engaged 29 executives from 26 leading life sciences companies. Segmentation analysis was key to examining trends and effective practices.
    Read More
    Best Practices In Aligning the Medical Affairs Function to Meet Its Role in a Changing Healthcare Environment (ID POP-251)
    This study engaged executives from 30 leading health care companies. Segmentation analysis was key to examining trends and effective practices.
    Read More
    Schedule a Meeting with Medical Affairs Experts

    Weekly Medical Affairs Research Release

    medical affairs consortium infographic


    Medical Affairs Collateral 2015





     
    ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE
    Quick Links  Product RSS Feed
    Payment gateway
    SSL Certificate
    Follow us: 
    linkedin twitter slideshare youtube google + pinterest

    All contents copyright 1998-2020 Best Practices, LLC (919) 403-0251
    Read our Terms and Conditions of Use, Privacy Policy and Copyright Information